Jaime Vieser Net Worth 2026 Estimate and How It’s Calculated

Jaime Vieser's net worth, based on publicly disclosed stock holdings tracked through SEC Form 4 filings, is estimated somewhere between roughly $46,000 and $1.92 million depending on which source you check and when. That wide range tells you something important right away: none of these figures are a full balance-sheet picture. They only capture the value of shares he holds in publicly traded companies, mainly Alaunos Therapeutics (ticker: TCRT). His real net worth, factoring in his 30-plus years in investment management, private fund stakes, and any real estate, is almost certainly higher but is not publicly verifiable.

Who Jaime Vieser Is (and Why People Search His Net Worth)

Jaime W. Vieser is a U.S.-based finance executive with a career spanning over three decades in investment management and investment banking. He is best known in public records as the co-founder and co-managing partner of Castle Hill Asset Management LLC, a private investment firm, and as CEO of Brushwood LLC, a position he has held since June 2017. He also serves as a board director at Alaunos Therapeutics (formerly ZIOPHARM Oncology), a role he has held since December 2020. Earlier in his career he worked at Deutsche Bank and Bankers Trust, primarily in leveraged finance and high-yield debt. His LinkedIn profile places him in Summit, New Jersey, which aligns with the SEC filings that identify him as Jaime W. Vieser.

Searches for his net worth are almost entirely driven by his insider status at Alaunos Therapeutics. When a corporate insider buys, sells, or receives shares, that transaction is disclosed in an SEC Form 4 filing that is publicly indexed. Sites that aggregate those filings, like GuruFocus, Benzinga, and MarketScreener, automatically generate a net-worth estimate from the disclosed holdings. That triggers search interest from investors, journalists, and anyone curious about the people steering biotech companies. If you are looking up Juan Sebastian Veron net worth specifically, the same limitation applies: public estimates often rely on disclosures rather than a complete view of total assets.

Current Estimated Net Worth and the Range You Should Know

Here is what the major tracking sites show as of mid-2026, pulled from their most recent publicly available snapshots: For additional context and the latest updates on juanse laverde net worth, check the most recent public filings and tracking-site estimates.

The huge gap between GuruFocus's $45,547 and Benzinga's $1.92 million is mostly explained by timing. Alaunos Therapeutics has gone through dramatic stock price volatility. Benzinga's estimate was calculated in September 2024, when the share price and reported holdings produced a much higher number. By early 2026, the stock value had dropped significantly, pulling the MarketScreener and GuruFocus figures down with it. So when you see wildly different numbers across sites, it is usually the stock price movement doing the work, not different underlying data. All of these estimates are anchored to Vieser's SEC-disclosed TCRT holdings, which include both direct shares and indirect holdings through Brushwood LLC. His SEC CIK is listed by Benzinga as 0001846045, which is the cleanest way to pull his exact filing history yourself.

How Net Worth Gets Estimated for Public Figures Like This

For a corporate insider like Jaime Vieser, net worth estimates on finance tracking sites work in a pretty mechanical way. When an officer, director, or major shareholder buys or receives shares, they are legally required to file an SEC Form 4 within two business days. Sites like GuruFocus, Benzinga, and MarketScreener ingest those filings automatically, tally up the reported share count, multiply by the current market price, and display that product as a net worth figure. It is a stock-value snapshot, nothing more.

GuruFocus is explicit about this on its own pages: the figure is derived exclusively from SEC Form 4 disclosures and assumes the insider still holds the shares reported in those transactions. It does not account for any shares sold off-record between filings, any private assets, real estate, cash, or other investments. Benzinga follows the same logic and timestamps its recalculations, which is useful because you can at least see when the number was last refreshed. MarketScreener updates more frequently, which is why their figures shift month to month as the stock price moves.

The core caveat to keep in mind: these are floor estimates, not ceilings. They tell you the minimum disclosed public-market wealth tied to one company's stock. For someone like Vieser, who co-founded a private asset management firm and manages a private investment vehicle (Brushwood LLC), the actual wealth picture almost certainly includes private fund stakes, carried interest, and other non-public holdings that never appear in Form 4 filings.

Where His Income Actually Comes From

Primary Earnings: Private Investment Management

Vieser's primary wealth engine is almost certainly Castle Hill Asset Management, the firm he co-founded and co-manages. Private asset management generates income through management fees (typically 1 to 2 percent of assets under management annually) and performance fees or carried interest (often 20 percent of profits above a hurdle rate). Neither of those income streams is publicly disclosed because Castle Hill is a private firm. This is also the biggest reason why his true net worth is impossible to estimate with precision from public data alone. If you are searching for Borja Voeser net worth, keep in mind that the same public-data limits apply and the numbers can change as SEC filings and stock prices update true net worth.

Secondary Earnings: Board Compensation at Alaunos Therapeutics

As a board director at Alaunos Therapeutics since December 2020, Vieser receives director compensation, which for small-cap biotech companies typically includes an annual cash retainer (commonly $30,000 to $60,000 per year for a non-executive director) plus equity grants. The SEC Form 4 filed for a share grant of 6,515 shares at $2.59 per share confirms he has received equity compensation directly. Those grants are what trigger the Form 4 disclosures and what the net-worth tracking sites are calculating from.

Earlier Career: Bankers Trust and Deutsche Bank

Vieser's earlier career in leveraged finance and high-yield debt at Bankers Trust and Deutsche Bank would have built his foundational wealth during some of the most lucrative periods in investment banking (the 1990s through 2000s). While those earnings are historical and unverifiable now, they are relevant context for understanding why someone with his background is capable of co-founding and managing a private investment firm rather than simply working for one.

Assets and Lifestyle Signals: What Is Actually Verifiable

Hard asset data on Jaime Vieser is limited. No real estate records have surfaced in public searches tied specifically to him, and there are no verifiable reports of major luxury purchases, vehicles, or high-profile spending. What does emerge as a lifestyle signal is his membership at Somerset Hills Country Club in New Jersey, where he was listed as Men Club Champion in 2021. Club membership at a private New Jersey country club is a reasonable indicator of upper-middle to affluent lifestyle, though it says nothing specific about net worth.

His residence in Summit, New Jersey (confirmed via LinkedIn and consistent with SEC filings) is worth noting for context. Summit is one of the wealthier towns in Union County, with median home values well above $1 million. Living there is consistent with a multi-decade career in investment management, though it does not prove any specific wealth level on its own.

Name Confusion and Who Else Shows Up as Jaime Vieser

This is an area worth paying attention to if you are doing any serious research. A LinkedIn directory search for 'Jaime Vieser' returns at least three distinct individuals, and not all of them are the finance executive described in this article. If you are trying to confirm you have the right person, here are the specific identifiers that distinguish Jaime W. Vieser, the investment executive:

• Middle initial W. (full name Jaime W. Vieser, as listed in SEC filings)
• Location: Summit, New Jersey
• Employer association: Castle Hill Asset Management LLC and Brushwood LLC
• SEC CIK: 0001846045 (Benzinga lists this directly, and you can verify it on SEC EDGAR)
• Board role: Alaunos Therapeutics director since December 2020
• Career history: Deutsche Bank, Bankers Trust (leveraged finance and high yield)

There is also a passing reference in a 2019 annual report PDF to a 'Jaime' starting a business venture, but there is no confirmed link between that mention and this individual. Without matching location, employer, or career details, that reference should not be used to draw conclusions about Jaime W. Vieser's business activities. The safest verification method is always to start with the SEC CIK number and pull Form 4 filings directly from EDGAR, since those are filed under the individual's legal name and assigned a unique identifier.

How Net Worth Estimates Change Over Time (and How to Re-Check)

The variation in the numbers above, from $45,547 to $1.92 million across roughly 18 months, shows exactly how volatile stock-based net worth estimates can be. Alaunos Therapeutics is a small-cap biotech company, and small-cap biotechs can swing 50 to 90 percent in value within a single year. Every time the stock price moves, every site that multiplies shares-held by current price produces a new number. That is why MarketScreener showed $152,932 in February 2026 and then $138,863 just two months later in April 2026: the stock price drifted lower.

If you want to keep the estimate current, the most reliable approach is to go directly to SEC EDGAR and search for Form 4 filings under CIK 0001846045. If you are comparing overall claims such as "juan villalonga net worth", use the same idea of checking the newest, most directly sourced disclosures before trusting any site-wide estimate. Each filing will show you the most recent transaction, the number of shares held after the transaction, and any indirect holdings (like those held via Brushwood LLC). Multiply that share count by the current TCRT stock price to get an up-to-date floor estimate. That is exactly what GuruFocus, Benzinga, and MarketScreener are doing automatically, just with a potential lag of days to weeks. If you are specifically comparing figures for Jordi Vilasuso net worth, use the same SEC Form 4-backed method rather than trusting one static number.

It is also worth checking in after any major Alaunos Therapeutics news: clinical trial results, FDA decisions, partnership announcements, and financing rounds all move small biotech stocks sharply. Any of those events could push his disclosed stock value up or down by tens of thousands of dollars overnight. His private wealth through Castle Hill Asset Management will remain opaque unless the firm registers with the SEC in a way that requires public disclosure of assets under management, which is not currently the case.

For context among similar profiles on this site, figures for finance-adjacent executives and directors tend to follow the same pattern as what you see here: the public number is just the tip of the iceberg, with private investments and business equity making up the bulk of actual wealth. You might also see search interest for Juan Villareal, because people often try to connect entertainers’ public visibility with estimated net worth figures. Readers looking at profiles like those of other Latin-connected business figures will recognize the same dynamic, where disclosed stock holdings give a starting point but not a full picture.